Grandfield & Dodd LLC Lowers Stock Position in Intuitive Surgical, Inc. $ISRG

Grandfield & Dodd LLC cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,756 shares of the medical equipment provider’s stock after selling 450 shares during the period. Grandfield & Dodd LLC’s holdings in Intuitive Surgical were worth $2,041,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of ISRG. Ignite Planners LLC boosted its position in Intuitive Surgical by 8.8% during the 2nd quarter. Ignite Planners LLC now owns 1,233 shares of the medical equipment provider’s stock valued at $639,000 after acquiring an additional 100 shares in the last quarter. Oak Harvest Investment Services lifted its position in shares of Intuitive Surgical by 4.8% during the second quarter. Oak Harvest Investment Services now owns 6,215 shares of the medical equipment provider’s stock valued at $3,377,000 after buying an additional 287 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. boosted its holdings in shares of Intuitive Surgical by 2.3% in the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 42,757 shares of the medical equipment provider’s stock valued at $23,222,000 after buying an additional 957 shares in the last quarter. Arvest Bank Trust Division grew its position in shares of Intuitive Surgical by 1,288.6% in the 2nd quarter. Arvest Bank Trust Division now owns 5,846 shares of the medical equipment provider’s stock worth $3,177,000 after buying an additional 5,425 shares during the last quarter. Finally, Allianz SE raised its stake in shares of Intuitive Surgical by 19.7% during the 2nd quarter. Allianz SE now owns 20,780 shares of the medical equipment provider’s stock worth $11,292,000 after acquiring an additional 3,415 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Argus raised their target price on shares of Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Rothschild & Co Redburn upped their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Insider Transactions at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the sale, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 116,164 shares of company stock valued at $61,916,172. 0.70% of the stock is owned by insiders.

Intuitive Surgical Trading Down 1.2%

Shares of NASDAQ ISRG opened at $565.51 on Friday. The stock has a market cap of $202.72 billion, a price-to-earnings ratio of 74.80, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a 50 day simple moving average of $480.86 and a two-hundred day simple moving average of $502.93.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the company posted $1.84 earnings per share. The firm’s revenue was up 22.9% compared to the same quarter last year. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.